APOLLO HOSPITALS ENTER. L vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs TORNTPHARM on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
74.52
13.42
P/B ratio
19.76
0.11%
Dividend yield
0.78%
₹135.04
EPS
₹63.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
27.40%
18.00%
Return on capital
15.00%
15.00%
EBITDA margin
33.00%
7.94%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
13.27%
33.39%
Profit CAGR (3Y)
19.75%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹1.61L Cr
₹25,228 Cr
Revenue
₹13,980 Cr
₹2,003 Cr
Net profit
₹2,138 Cr
0.90
Debt / equity
1.79
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
TORRENT PHARMACEUTICALS L
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
APOLLO HOSPITALS ENTER. L full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.